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11 ABSTRACT: Absorption of glucose, via intestinal Na+/glucose cotransporter 1 (SGLT1), activates salt and water absorption
12 and is an eﬀective route for treating Escherichia coli (E. coli)-induced diarrhea. Activity and expression of SGLT1 is regulated by
13 sensing of sugars and artiﬁcial/natural sweeteners by the intestinal sweet receptor T1R2-T1R3 expressed in enteroendocrine
14 cells. Diarrhea, caused by the bacterial pathogen E. coli, is the most common post-weaning clinical feature in rabbits, leading to
15 mortality. We demonstrate here that, in rabbits with experimentally E. coli-induced diarrhea, inclusion of a supplement
16 containing stevia leaf extract (SL) in the feed decreases cumulative morbidity, improving clinical signs of disease (p < 0.01). We
17 show that the rabbit intestine expresses T1R2-T1R3. Furthermore, intake of SL enhances activity and expression of SGLT1 and
18 the intestinal capacity to absorb glucose (1.8-fold increase, p < 0.05). Thus, a natural plant extract sweetener can act as an
19 eﬀective feed additive for lessening the negative impact of enteric diseases in animals.
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21 ■ INTRODUCTION
22 Na+/glucose cotransporter 1, SGLT1, is the major route for
23 absorption of glucose across the intestinal brush border
24 membrane. Absorption of glucose via SGLT1 activates
25 electrolyte and water absorption. In humans, this strategy has
26 been used in oral rehydration therapy, which is the safest and
27 most eﬀective remedy for treating life-threatening diarrhea
28 induced by agents such as Vibrio cholerae and Escherichia coli.1,2
29 The condition is caused by toxic peptides produced by bacteria
30 stimulating the conversion of guanosine 5′-triphosphate
31 (GTP) to cyclic guanosine 5′-monophosphate (cGMP) by
32 the enzyme guanylate cyclase. Increased intracellular cGMP
33 inhibits intestinal ﬂuid uptake, resulting in net ﬂuid secretion
34 and thus diarrhea.
35 The gut epithelium can sense sugars and artiﬁcial sweeteners
36 via the sweet receptor comprising Taste family 1 Receptor 2
37 (T1R2) and 3 (T1R3) expressed on the luminal membrane of
38 enteroendocrine cells (EEC).3,4 This results in secretion of gut
39 hormones, glucagon-like peptide 1 (GLP-1), glucagon-like
40 peptide 2 (GLP-2), and glucose-dependent insulinotropic
41 peptide (GIP) from EEC.5,6 GLP-2 upregulates SGLT1
42 activity and expression7,8 in neighboring absorptive enterocytes
43 via a neuro-paracrine pathway.6,9 GLP-2 also increases the
44 villus height and intestinal barrier function,10,11 thereby
45 promoting gut health. These eﬀects have also been reported
46 in piglets12 and calves and ruminants.13
47 The sweet taste receptor is similarly activated by natural,
48 high-intensity sweeteners, such as stevia,14 leading to increased
49expression and activity of SGLT1, providing the capacity for
50enhanced glucose (electrolyte and water) absorption.
51Rabbits are raised for a variety of commercial reasons. Their
52meat, wool, and fur are valuable commodities, as is their
53nitrogen-rich manure and high protein milk. They are also very
54popular as household pets. Diarrhea is the most common post-
55weaning clinical feature in rabbits, leading to signiﬁcant rates of
56mortality. With current trends aimed at decreasing the use of
57antibiotics, feed additives that can improve rabbit health and
58performance in the face of disease is highly desirable. This is
59especially relevant in Europe, where antibiotic use in animal
60feed is already banned, and the use of natural alternatives, for
61disease prevention, is encouraged. Furthermore, in Europe, the
62use of artiﬁcial sweeteners, used routinely in farm animal
63nutrition,12,13 is prohibited as supplements in rabbit feed. It is
64not known if a natural high-intensity sweetener such as stevia
65leaf extract (SL), which can be used in rabbit feed, will elicit
66similar eﬀects as seen with artiﬁcial sweeteners in farm animals,
67assisting to prevent and ameliorate enteric diseases in rabbits.
68Here, we show that when rabbits are challenged with
69colibacillosis, inclusion of a supplement containing SL in rabbit
70feed leads to a signiﬁcant reduction in diarrhea and bloat,
71improving the health status. Furthermore, we demonstrate that
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72 the rabbit intestine expresses the intestinal sweet receptor
73 T1R2-T1R3 and that inclusion of SL in the feed results in
74 upregulation of SGLT1 activity and protein and mRNA
75 abundance in the small intestine. Thus, a better understanding
76 of the molecular mechanism underlying intestinal nutrient
77 absorption provides a rational strategy for using a natural feed
78 additive for alleviating enteric disorders and promoting the
79 health and well-being of animals.
80 ■ MATERIALS AND METHODS
81 Chemicals. SL supplement (containing 17.75% stevia leaf extract
82 and 2% capsicum oleoresin (for concentration see below); Sucram
83 TakTik) was from Pancosma, Rolle, Switzerland. Zymo Total RNA
84 isolation kit with on-column DNase 1 digestion was from Cambridge
85 Bioscience, Cambridge, UK. dT20 primers and superscript III reverse
86 transcriptase was from Life Technologies, Paisley, UK, and QIAquick
87 PCR puriﬁcation kit was from Qiagen, Crawley, West Sussex, UK.
88 Consensus primers for mammalian T1R2 and T1R3 were purchased
89 from Eurogentec, Seraing, Belgium. Q5 Hot Start High-Fidelity DNA
90 Polymerase was purchased from New England Biolabs, Hitchin,
91 Herts, UK, and pGEM-T Easy vector was from Promega, South-
92 ampton, UK. SYBR green JumpStart Taq ReadyMix, dithiothreitol,
93 benzamidine, phenylmethylsulfonyl ﬂuoride, Bio-Max Light Chem-
94 iluminescence Film, β-actin antibody (clone AC-15), D.P.X. neutral
95 mounting medium, donkey serum, 10% neutral buﬀered formalin, and
96 Mayer’s Hemalum (3.3 mM Mayer’s Hemalum-hematoxylin, 1 mM
97 sodium iodate, and 0.42 mM potassium alum) were purchased from
98 Sigma-Aldrich, Poole, Dorset, UK. Bio-Rad protein assay solution and
99 polyvinylidene diﬂuoride (PVDF) membrane were from Bio-Rad
100 Laboratories Ltd., Hemel Hempstead, UK. The antibody to SGLT1
101 was raised in rabbits (custom synthesis) to a recombinant peptide
102 corresponding to amino acids 554−640 of rabbit SGLT1 protein.
103 Horseradish peroxidase-linked secondary antibodies were purchased
104 from DAKO Ltd., Cambridge, UK. Immobilon Western Chemilumi-
105 nescent HRP Substrate and cellulose acetate/nitrate ﬁlter were
106 purchased from Millipore, Hertfordshire, UK, and [U-14C]-D-glucose
107 (10.6 GBq/mmol) was from Perkin Elmer, Seer Green, Bucks, UK.
108 Scintillation ﬂuid (Optiphase HiSafe 3) was purchased from Fisher
109 Scientiﬁc, UK, and Eosin Y solution (1% (w/v) eosin aqueous) was
110 from HD Supplies, Buckingham, Bucks, UK. Chromogranin A
111 antibody (ab8204) was from Abcam, Cambridge, UK. Antibodies to
112 T1R2 (sc-50306) and T1R3 (sc-22458) were from Santa Cruz
113 Biotechnology, Inc., Heidelberg, Germany, and IgG Cy3- FITC-
114 conjugated secondary antibodies were from Stratech Scientiﬁc,
115 Newmarket, UK. 4′,6-Diaminido-2-phenylindole (DAPI) was pur-
116 chased from Vector Laboratories, Peterborough, UK.
117 Phase 1. Animals, Treatments, and Experimental Conditions.
118 The animal experiment was conducted at the Talhouet Research
119 Center (Saint Nolﬀ, France). All animal procedures were approved by
120 the Ethical Committee for Animal Experimentation of NEOVIA and
121 by the Ministry of Higher Education of Research and Innovation,
122 France (experimental reference #03835.03). Animal numbers were
123 determined based on power calculations conducted using data from
124 previous experiments performed in the same facility wherein
125 colibacillosis challenge was used. Thirty-six day-old Souche Hyplus
126 PS59 rabbits (http://www.hypharm.fr; n = 300) were weaned,
127 blocked by sex, litter origin, and body weight and assigned to one of
128 four dietary treatments (n = 75/trt): unsupplemented diet or a diet
129 supplemented with 50, 75, or 100 ppm SL containing maximum of
130 3.3, 4.9, and 6.5 μM capsaicin. Animals were housed in cages (ﬁve
131 rabbits per cage) with ad libitum access to feed and water. Rabbit feed
132 was formulated for a typical fattening ration containing 15.5% crude
133 protein and a metabolizable energy (ME) of 22.9 kcal/100 g feed. All
134 feed was free of antibiotics and medications, including coccidiostats.
135 The room was maintained at 19 °C and illuminated between 0700
136 and 1700 each day. All animals were monitored daily.
137 On day 44 of age (day 0 of infection), all rabbits were orally
138 inoculated with 5 × 106 CFU/mL E. coli O103 LY265 inoculum
139(INRA, Nouzilly, France; dose determined in preliminary experiments
140and validated in several separate experiments).
141Measurements. Feed intake was measured daily per cage by
142weighing of refusals. Live weights of individual rabbits were measured
143on days −2, 5, 12, 19, and 26 post infection (corresponding to 42, 49,
14456, 63, and 70 days of age), and average daily gain (ADG) was
145calculated from individual body weights. Feed eﬃciency (G:F; gain/
146feed) was calculated per cage. Morbidities [visual signs of diarrhea
147and discoloration of feces, bloat (swollen stomach), sunken eyes, dull
148fur, and low energy and mobility] were assessed daily by two
149technicians trained by a veterinarian. Morbidities were not quantiﬁed
150but were simply noted as present or absent based on subjective visual
151observation by both technicians. The same technicians performed the
152scoring throughout the study to avoid variation due to the observer.
153Mortalities were also recorded daily; dead animals were removed from
154cages upon detection, and visible clinical signs were noted. At the
155peak of mortality during clinical disease, a random selection of rabbits
156(n = 10) was necropsied to verify colibacillosis as the cause of death
157(via E. coli serotyping of intestinal content).
158The experiment ended on day 26 post infection (when animals
159were 70 days of age), and all remaining animals were euthanized by a
160trained technician. The average body weight at 70 days of age was
161multiplied by the number of animals alive to estimate production
162weight per treatment.
163Statistical Analysis. Data were analyzed by ANOVA using the SAS
164Mixed Procedure with a Dunnett’s adjustment for multiple
165comparisons and orthogonal contrasts to test for linearity. Treatment
166and time were ﬁxed eﬀects, whereas sex and cage were treated as
167random eﬀects. Statistical signiﬁcance was set at p < 0.05.
168Phase 2. The experiments in phase 2 were undertaken to
169understand the molecular mechanisms underlying the intestinal
170response of rabbits to SL.
171Animals, Dietary Trial, and Gut Tissue Sampling. The animal
172experiment was conducted at the Talhouet Research Center (Saint
173Nolﬀ, France). All animal procedures were approved by the Ethical
174Committee for Animal Experimentation of NEOVIA and the Ministry
175of Higher Education of Research and Innovation, France (exper-
176imental reference #03835.03). Animal numbers were determined
177using gut responses and variation associated with supplementation
178with artiﬁcial sweeteners reported in published articles.6,12,13 Forty-
179two 60 day-old Souche Hyplus PS59 rabbits (http://www.hypharm.
180fr) were blocked by sex and body weight and assigned to one of two
181dietary treatments starting on day 61 of age (n = 21 rabbits/
182treatment): unsupplemented diet or a diet supplemented with 75 ppm
183SL (dose chosen based on responses observed in phase 1). Animals
184were housed in cages (ﬁve rabbits per cage) with ad libitum access to
185feed and water. Rabbit feed was formulated for a typical fattening
186ration containing 15.5% crude protein and an ME of 22.9 kcal/100 g
187feed. All feed was free of antibiotics and medications, including
188coccidiostats. The room was maintained at 19 °C and illuminated
189between 0700 and 1700 each day. After the 9 day treatment period
190(the period of 9 days was selected to cover the gut epithelial cell
191turnover that takes 4−5 days in the majority of species and was
192extended to 9 days due to travel delays for the researcher from the UK
193traveling to France for harvesting intestinal tissues) at 70 days of age
194(same slaughter age as phase 1), all rabbits were weighed and
195euthanized by intracardiac injection of Euthasol after sedation starting
196at 9 am. Intestinal tissues were removed: duodenal, 10 cm distal to the
197pyloric ceca; ileal, 10 cm proximal from the ileocecal valve; and
198jejunal, at the midpoint between the pyloric ceca and ileocecal valve.
199Tissue samples were collected from 10 rabbits/treatment (blocked by
200sex and body weight at slaughter), rinsed in ice-cold saline, and either
201placed into cryovials or wrapped in aluminum foil and frozen
202immediately in liquid nitrogen or pinned to dental plastic and ﬁxed in
20310% neutral buﬀered formalin at 4 °C. Fixed tissues were transferred
204to 20% sucrose in phosphate-buﬀered saline (PBS) after 24 h and
205stored at 4 °C. Frozen tissues were stored at −80 °C before shipping
206to the UK on dry ice, whilst ﬁxed samples were shipped to the UK on
207wet ice for subsequent analysis.
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208 Cloning of Rabbit T1R2 and T1R3. Total RNA was isolated from
209 rabbit intestinal tissues using the Zymo Total RNA isolation kit with
210 on-column DNase 1 digestion. RNA was quantiﬁed by UV
211 spectrophotometry (assuming an OD260 value of 1 = 40 μg/mL)
212 and integrity determined by agarose gel electrophoresis. Comple-
213 mentary DNA (cDNA) was prepared using oligo dT20 primers and
214 superscript III reverse transcriptase, puriﬁed using the QIAquick PCR
215 puriﬁcation kit, and quantiﬁed by UV spectrophotometry (assuming
216 an OD260 value of 1 = 33 μg/mL). Consensus primers for mammalian
t1 217 T1R2 and T1R3 are listed in Table 1. Each PCR reaction mix
218 contained 0.5 μM of each forward and reverse primer, 0.5 U of Q5
219 Hot Start High-Fidelity DNA Polymerase, and 25 ng of template
220 cDNA in a ﬁnal volume of 25 μL. Polymerase chain reaction (PCR)
221 cycling was carried out as follows: initial denaturation at 98 °C for 1
222 min, 25 cycles of denaturation at 98 °C for 10 s, annealing for 10 s,
223 and extension at 72 °C for 30 s followed by a ﬁnal extension step at 72
224 °C for 2 min. PCR amplicons were gel puriﬁed using 1% agarose gels,
225 cloned into the pGEM-T Easy vector, and custom sequenced
226 (Euroﬁns-MWG, Ebersberg, Germany). Sequence alignments and
227 amino acid translations were performed using commercial software
228 (Vector NTI, Life Technologies).
229 The radial phylogram shown in Figure 7, depicting the
230 phylogenetic relationship of rabbit T1R3 to various mammalian
231 homologs, was constructed by neighbor-joining analysis15 of distance
232 matrices generated using the PROTDIST program (Jones−Taylor−
233 Thornton similarity model)16 as part of the phylogenetic inference
234 package, PHYLIP.17
235 Quantitative PCR. Relative mRNA expression in the intestine was
236 determined by quantitative real-time PCR (qPCR). cDNA was
237 prepared from total RNA as described above and diluted to 5 ng/μL.
238 Primers to rabbit SGLT1, β-actin (ACTB), RNA polymerase II
239 (POLR2A), and β-2-microglobulin (B2M) were designed using
240 Primer-BLAST18 and purchased from Eurogentec (see Table 1). Each
241 qPCR reaction consisted of 25 ng of cDNA template, 1X SYBR green
242 JumpStart Taq ReadyMix, and 900 nM of each primer in a total
243 volume of 25 μL. The PCR cycling consisted of initial denaturation at
244 95 °C for 2 min followed by 45 cycles of 95 °C for 15 s and 60 °C for
245 1 min. Assays were performed in triplicate using a RotorGene 3000
246 (Qiagen) with relative abundance calculated using RG-3000
247 comparative quantiﬁcation software (Qiagen). Abundance of
248 SGLT1 mRNA was normalized to the genomic mean of ACTB,
249 POLR2A, and B2M housekeeping genes, the expression of which did
250 not change throughout the study. qPCR assays without the RT step
251 were routinely employed as negative controls and showed no
252 ampliﬁcation. Melt curve analysis showed no primer dimer formation
253 in the assays. PCR amplicons were cloned into pGEM-T easy vectors
254 and sequenced to conﬁrm veracity.
255 Preparation of Brush Border Membrane Vesicles. Brush border
256 membrane vesicles (BBMV) were isolated from diﬀerent regions of
257 rabbit small intestinal tissues based on the procedure described by
258 Shirazi-Beechey et al.,19 with modiﬁcations outlined by Rowell-
259 Schaf̈er et al.20 and Dyer et al.21 All steps were carried out at 4 °C.
260Tissues were thawed in a buﬀer solution (100 mM mannitol, 2 mM
261HEPES/Tris pH 7.1 with protease inhibitors, 0.5 mM dithiothreitol,
2620.2 mM benzamidine, and 0.2 mM phenylmethylsulfonyl ﬂuoride),
263cut into small pieces, and vibrated for 1.5 min at speed 5 using a
264FUNDAMIX vibro-mixer (DrM, Dr. Mueller AG, Maennedorf,
265Switzerland) in order to free intestinal epithelial cells. The ﬁltrate
266was then homogenized using a Polytron (Ystral, Reading, Berkshire,
267UK) for 20 s. Next, MgCl2 was added to a ﬁnal concentration of 10
268mM and the solution stirred on ice for 20 min. The suspension was
269then centrifuged for 10 min at 3000g (SS34 rotor, Sorvall, UK), and
270the resulting supernatant was spun for 30 min at 30,000g. The pellet
271was suspended in buﬀer (100 mM mannitol, 0.1 mM MgSO4, and 20
272mM HEPES/Tris pH 7.1) and homogenized with 10 strokes of a
273Potter Elvehjem Teﬂon hand-held homogenizer before centrifuging
274for 30 min at 30,000g. The ﬁnal pellet was resuspended in an isotonic
275buﬀer solution (300 mM mannitol, 0.1 mM MgSO4, and 20 mM
276HEPES/Tris pH 7.4) and homogenized by passing through a 27-
277gauge needle several times. The protein concentration in the BBMV
278was estimated by its ability to bind Coomassie blue according to the
279Bio-Rad assay technique. Porcine γ-globulin was used as the standard.
280Inclusion of protease inhibitors in the buﬀers is essential for avoiding
281SGLT1 protein degradation.
282In preparation for western blot analysis, aliquots of freshly prepared
283BBMV were diluted with the sample buﬀer (62.5 mM Tris/HCl pH
2846.8, 10% (v/v) glycerol, 2% (w/v) SDS, 0.05% (v/v) β-
285mercaptoethanol, and 0.05% (w/v) bromophenol blue) and stored
286at −20 °C until use. The remaining BBMV were divided into aliquots
287and stored in liquid nitrogen or used immediately for glucose uptake
288studies.
289Western Blotting. The abundance of SGLT1 and β-actin proteins
290in the BBMV isolated from rabbit small intestine was determined by
291western blotting as described previously.12,21 Protein components of
292BBMV (20 μg) were separated by sodium dodecyl sulfate (SDS)-
293polyacrylamide gel electrophoresis on 8% (w/v) polyacrylamide mini
294gels, containing 0.1% (w/v) SDS, and electrotransferred to
295polyvinylidene diﬂuoride (PVDF) membranes. The PVDF mem-
296branes were blocked for 1 h at room temperature (RT) in PBS
297containing 0.5% (w/v) nonfat dried milk and 0.05% (v/v) Tween-20
298(PBS-TM). Incubation for 1 h with the SGLT1 antibody diluted
2991:1000 in PBS-TM then followed.
300Immunoreactive bands were detected by incubation for 1 h with
301aﬃnity puriﬁed horseradish peroxidase-linked anti-rabbit secondary
302antibody diluted 1:2000 in PBS-TM and visualized using the
303Immobilon Western Chemiluminescent HRP Substrate and Bio-
304Max Light Chemiluminescence Film. The intensity of the
305immunoreactive bands was quantiﬁed using scanning densitometry
306(Total Lab, Newcastle-upon-Tyne, UK).
307The PVDF membranes were stripped by 3 × 10 min washes in 137
308mM NaCl and 20 mM glycine/HCl (pH 2.5) and then reprobed with
309a monoclonal antibody to β-actin used as a loading control. Blocking
310solution consisted of 0.1% (v/v) Triton X-100 and 0.1 mM EDTA in
311PBS (PBS-TE) and 5% (w/v) skimmed milk powder. PBS-TE was
Table 1. Primers Used for PCR and qPCR
primer name accession no. sequence Tm (°C)
RbACTB S NM_001101683 5′-CCTTCTACAACGAGCTGCGAG-3′ 51.4
RbACTB AS NM_001101683 5′-GCCCTCGTAGATGGGTACTG-3′ 49.9
RbPOLR2A S XM_017348893.1 5′-ACGCTGCTCTTCAACATCCA-3′ 60
RbPOLR2A AS XM_017348893.1 5′-CCAGCGTAGTGGAAGGTGTT-3′ 60
RbB2M S XM_008269078.2 CTAGTCTTGTTCCCCTGCCT 58.9
RbB2M AS XM_008269078.2 ATCAATCTGGGGCGGATGAAA 60
RbT1R2 S XM_017346518 5′-TCTGGAACGTCAGCTTCACC-3′ 52.5
RbT1R2 AS XM_017346518 5′-GTGCTTCAGCATGGGGTAGT-3′ 51.6
RbT1R3 S 5′-GCAAGTTCTTCAGCTTCTTCCT-3′ 51.5
RbT1R3 AS 5′-TACATGTTCTCCAGGAGCTGC-3′ 51.9
RbSGLT1 S NM_001101692 5′-TGTCAAGGCTGGCTGTATCC-3′ 51.4
RbSGLT1 AS NM_001101692 5′-CTCCTCTGGTTCCACGCAA-3′ 51.3
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312 used for the incubation and washing buﬀers. Horseradish peroxidase-
313 linked anti-mouse secondary antibody diluted 1:2000 in PBS-TE was
314 used and visualized as above.
315 Measurement of Na+-Dependent Glucose Uptake. Na+-depend-
316 ent glucose uptake into rabbit intestinal BBMV was measured as
317 described.12,19 The uptake of D-glucose was initiated by the addition
318 of 100 μL of incubation medium (100 mM NaSCN (or KSCN), 100
319 mM mannitol, 20 mM HEPES/Tris (pH 7.4), 0.1 mM MgSO4, 0.02%
320 (w/v) NaN3, and 0.1 mM [U-
14C]-D-glucose (10.6 GBq/mmol)) to
321 BBMV (100 μg of protein) at 37 °C. The reaction was stopped after 3
322 s by the addition of 1 mL of ice-cold stop buﬀer (150 mM KCl, 20
323 mM HEPES/Tris (pH 7.4), 0.1 mM MgSO4, 0.02% (w/v) NaN3, and
324 0.1 mM phlorizin). Aliquots (0.9 mL) of the reaction mixture were
325 removed and ﬁltered under vacuum through a 0.22 μm pore cellulose
326 acetate/nitrate ﬁlter. The ﬁlter was washed with 5 × 1 mL of ice-cold
327 stop buﬀer and placed in a vial containing 4 mL of scintillation ﬂuid,
328 and the radioactivity retained on the ﬁlter measured using a Tri-Carb
329 2910TR Liquid Scintillation Analyzer (PerkinElmer, Bucks, UK). All
330 uptakes were measured in duplicate.
331 Morphometry. Rabbit small intestinal tissues were ﬁxed and cryo-
332 protected before being embedded in OCT (Fisher Scientiﬁc, UK),
333 frozen at −20 °C, and then kept at −80 °C until use. Tissue blocks
334 were sectioned (10 μm) on a cryostat (Leica, CM 1900UV-1-1,
335 Milton Keynes, Buckinghamshire, UK) and thaw-mounted onto
336 polylysine-coated slides. Morphometric analysis was performed as
337 described previously.12 The sections were exposed to tap water for 1
338 min, transferred to Mayer’s Hemalum for 1 min, and washed gently
339 with running tap water for 5 min. They were stained with eosin Y
340 solution for 30 s and subsequently dehydrated by stepwise washing in
341 70% ethanol (v/v) for 2 × 1 min, absolute ethanol for 2 × 1 min, and
342 xylene for 3 × 1 min before mounting with the D.P.X. neutral
343 mounting medium.
344 Digital images were captured with an Eclipse E400 microscope and
345 DXM 1200 digital camera (Nikon, Kingston upon Thames, Surrey,
346 UK), analyzed using ImageJ software (Wayne Rasband, US National
347 Institutes of Health, Bethesda, MD), and calibrated using a 100 μm
348 gradient slide. The crypt depth and the villus height were measured as
349 the average distance from the crypt base to crypt-villus junction and
350 villus base to villus tip, respectively. The villus height and the crypt
351 depth measurements were taken from an average of 16 well-oriented
352 crypt-villus units. A minimum of three images were captured per
353 section with a minimum of eight sections prepared per animal, with
354 each section being ﬁve sections apart within the block. All images
355 were captured under the same conditions with care taken to ensure
356 that the same villus was not counted twice.
357 Immunohistochemistry. Immunohistochemistry was performed as
358 previously described.22 Tissue sections (10 μm thick, on polylysine
359 coated slides) were washed ﬁve times for 5 min each in PBS. Slides
360 were then incubated for 1 h in a blocking solution (10% (v/v) donkey
361 serum in PBS) at room temperature in a humidiﬁed chamber.
362 Subsequently, sections were incubated overnight at 4 °C with primary
363 polyclonal antibodies. The antibody to chromogranin A (1:100),
364 T1R2 (1:200), and T1R3 (1:200) were used. The T1R2 antibody was
365 raised against a peptide corresponding to residues 426−570 of mouse
366 T1R2 that shares 66% homology with rabbit T1R2 and T1R3 to a
367 peptide corresponding to the C-terminus of human T1R3. Cloned
368 rabbit T1R3 shares 69% homology to human T1R3. After incubation
369 of sections with primary antibodies, slides were washed ﬁve times for
370 5 min each in PBS and subsequently stained for 1 h at room
371 temperature using a 1:500 dilution of Cyanine 3 (Cy3)- or ﬂuorescein
372 isothiocyanate (FITC)-conjugated anti-goat, anti-rabbit, and anti-
373 mouse IgG secondary antibodies. The composition of the buﬀer
374 containing antibodies (primary or secondary) was 2.5% (v/v) donkey
375 serum, 0.25% (w/v) NaN3, and 0.2% (v/v) Triton X-100 in PBS.
376 Finally, slides were washed ﬁve times for 5 min each in PBS and then
377 mounted with the Vectashield Hard Set Mounting Medium with
378 (DAPI). Immunoﬂuorescent labeling of chromogranin A, T1R2, and
379 T1R3 proteins was visualized using an epiﬂuorescence microscope
380 (Nikon, Kingston-Upon-Thames, UK), and images were captured
381 with a digital camera (model C4742-96-12G04, Hamamatsu
382Photonics, Welwyn Garden City, UK). Omission of primary
383antibodies was routinely used as the control.
384Statistical Analysis. All parameters were tested for normality by
385the Shapiro−Wilk test. For comparison of SGLT1 expression in
386intestinal tissues and measurements of crypt-depth/villus height in
387intestinal tissues a Student’s two-tailed t-test was used to determine
388the statistical signiﬁcance (GraphPad Prism 5, GraphPad Software
389Inc., La Jolla, CA). The level of statistical signiﬁcance was set at p <
3900.05.
391■ RESULTS
392Phase 1 Studies. Assessment of Rabbit Performance.
393Rabbit daily weight gain, feed intake, and gain to feed ratios are
394 f1presented in Figure 1. E. coli inoculation markedly decreased
395daily weight gain (p < 0.001; Figure 1A) across all dietary
396treatments until surviving animals had recovered by day 19
397post infection (63 days of age). There was no eﬀect of dietary
398supplementation on daily weight gain (p > 0.70; Figure 1A).
399Feed intake was not aﬀected by inoculation (Figure 1B). There
Figure 1. Growth performance of rabbits supplemented with 0, 50,
75, or 100 ppm of an additive containing natural high-intensity
sweetener (SL) and inoculated with Escherichia coli on day 44 of age
(red arrow). Data presented are (least-squares) (LS) Means, with
pooled SEM per group indicated by error bars. (A) Daily weight gain.
(B) Daily feed intake. (C) Gain:feed.
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400 was a trend for an eﬀect of dietary treatment (p < 0.10) such
401 that the animals supplemented with 75 ppm SL consumed
402 more feed in the middle of the clinical phase of disease (day 12
403 post infection; 56 days of age; Figure 1B). Inoculation
404 markedly decreased eﬃciency of growth (p < 0.001; Figure
405 1C), and this was not inﬂuenced by dietary treatment (p >
406 0.50). None of the groups recovered to pre-inoculation feed
407 eﬃciency for the duration of the study.
408 Mortality and Morbidities. Rabbit rates of mortality are
f2 409 presented in Figure 2. The colibacillosis challenge had a strong
410 eﬀect and elicited a marked increase in mortality rate with peak
411 levels reached on day 19 post infection (63 days of age). There
412 was no eﬀect of dietary treatment on the percent rate of
413 mortality (p > 0.30), and cumulative death was increased by
414 inoculation (p < 0.001; Figure 2). The average body weight on
415 day 26 post infection (70 day of age) was multiplied by the
416 number of animals alive on that day to give production weights
417 of 112.5, 119.2, 121.2, and 111.9 g for animals supplemented
418 with 0, 50, 75, and 100 ppm SL, respectively.
f3 419 Morbidities (diarrhea and bloat) are presented in Figure 3.
420 The majority of morbidities observed were diarrhea, and this
421 was increased with inoculation (p < 0.001; Figure 3A). All
422 animals reached pre-inoculation levels by day 26 post infection
423 (70 d of age), and there was no eﬀect of dietary treatment on
424 percent morbidities (p > 0.40; Figure 3A). The cumulative
425 number of morbidities also increased with inoculation (p <
426 0.001; Figure 3B), and there was a signiﬁcant treatment eﬀect
427 characterized by fewer morbid animals in the 50 and 75 ppm
428 SL groups compared to control animals (p < 0.01; Figure 3B).
429 Phase 2 Studies. Rabbit SGLT1 Expression and Activity
430 Are Enhanced by Feed Supplementation with the Natural
431 High-Intensity Sweetener, Stevia Leaf. SGLT1 expression and
432 activity were determined along the length of the small intestine
433 in rabbits fed a diet supplemented with SL and the same diet
434 without SL (control diet). Irrespective of diets, levels of
435 SGLT1 mRNA, protein, and function were highest in the
436 duodenum (duodenum > jejunum > ileum). There was a 1.4-
437 fold (p < 0.05) and 1.3-fold (p < 0.001) increase in SGLT1
438 mRNA abundance in the duodenum and jejunum of rabbits
439 fed a diet supplemented with SL compared to control diet
f4 440 (Figure 4A). SGLT1 protein abundance measured in BBMV
441 increased by 1.6-fold (p < 0.001) and 1.6-fold (p < 0.001) in
442 the duodenum and jejunum of rabbits fed a diet supplemented
443with SL compared to control (Figure 4B). This was matched
444by a 1.8-fold (p < 0.050) and 1.7-fold (p < 0.050) increase in
445the initial rates of D-glucose transport into BBMV in the
446duodenum and jejunum of rabbits fed the diet supplemented
447with SL rather than the control diet (Figure 4C). No increases
448in either SGLT1 mRNA, protein abundance, or the initial rate
449of D-glucose transport into BBMV were observed in the ileum
450of rabbits fed the diet supplemented with SL compared to
451control diet (Figure 4). There was a 1.4-fold (p < 0.0010) and
4521.3-fold (p < 0.0010) increase in villus height in the duodenum
453 f5and jejunum of SL fed rabbits compared to controls (Figure 5).
454There was no diﬀerence in the average villus heights of control
455and SL fed rabbits in the ileum.
456Expression of T1R2 and T1R3 in the Rabbit Intestine. For
457rabbit T1R2, PCR primers were designed against the predicted
458mRNA sequence available on the National Center for
459Biotechnology Information (NCBI) nonredundant nucleotide
460database. PCR amplicons using rabbit jejunal cDNA and the
461designed T1R2 primers resulted in a 152 bp amplicon, which
462was found to be a 100% match to the predicted NCBI
463sequence, revealing that the rabbit intestine expresses T1R2
464 f6(Figure 6). An alignment of the full-length rabbit T1R2 mRNA
465sequence showed 55.3% homology with cow, pig, human,
466mouse, and rat T1R2.
467As no sequence information on rabbit T1R3 was available
468from the current release of the rabbit genome (NCBI
469OryCun2.0 Annotation Release 102), it was necessary to
470clone rabbit T1R3 to obtain mRNA sequence data and verify
471its expression in the rabbit intestine. PCR ampliﬁcation using
472rabbit jejunal cDNA and consensus mammalian T1R3 primers
Figure 2. Mortality of rabbits supplemented with 0, 50, 75, or 100
ppm of an additive containing natural high-intensity sweetener (SL)
and inoculated with Escherichia coli on day 44 of age (red arrow).
Data presented are LS Means, with pooled SEM per group indicated
by error bars. Results show the total number of dead animals over
time. Mortality was calculated by dividing the number of new deaths
recorded at each time point by the number of animals alive at the
previous time point and then multiplying by 100.
Figure 3. Morbidity (diarrhea, abnormal feces, and/or bloat) of
rabbits supplemented with 0, 50, 75, or 100 ppm of an additive
containing natural high-intensity sweetener (SL) and inoculated with
Escherichia coli on day 44 of age (red arrow). Data presented are LS
Means, with pooled SEM per group indicated by error bars. (A)
Percent morbidity over time. (B) Cumulative morbidity over time. *
= p < 0.05; ** = p < 0.01
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Figure 4. Expression and activity of SGLT1 in the intestine of control rabbits and in rabbits maintained on the same diet supplemented with SL.
Brush border membrane vesicles (BBMV) and RNA were isolated from small intestinal tissues of rabbits fed either a control diet (C) or a diet
supplemented with an additive containing natural high-intensity sweetener (SL). (A) Level of SGLT1 mRNA abundance normalized to β-actin,
RNA polymerase II, and β-2-microglobulin mRNA. (B) Expression of SGLT1 and β-actin proteins in BBMV isolated from the small intestine
assessed by western blotting (left panel). Densitometric analysis of SGLT1 protein abundance normalized to β-actin (right panel). (C) Initial rates
of Na+-dependent [U14C]-D-glucose uptake into BBMV. Data were generated in triplicate. Results are shown as mean ± SEM; n = 7 animals.
Statistically signiﬁcant results determined using a Student’s two-tailed t-test where * = p < 0.050; ** = p < 0.010; *** = p < 0.001.
Figure 5.Morphometric analysis of the rabbit intestine. (A) Representative light micrographs of small intestinal tissues of control and natural high-
intensity sweetener (SL) fed rabbits. Images were obtained at 4× magniﬁcation. (B) Morphometric analyses of villus height and crypt depths are
shown as histograms, in (μm) ± SEM. Control (box), SL-fed (solid box); n = 5 animals. Statistically signiﬁcant results were determined using
Student’s two-tailed t-test where ** = p < 0.010.
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473 resulted in a 1221 bp fragment that was screened against the
474 National Center for Biotechnology Information (NCBI)
475 nonredundant nucleotide database via BlastN,23 identifying
476 the ampliﬁed sequence as being homologous to T1R3 in many
477 other mammalian species. The mRNA fragment was
478 subsequently translated to produce a sequence of 407 amino
479 acids (corresponding to residues 116−515 of human T1R3).
480 Phylogenetic analysis was performed to construct a radial
481 phylogram depicting the relationship of rabbit T1R3 to
482 homologs in various other mammalian species for which
f7 483 sequence information was available (Figure 7). The NCBI
484 accession number for the mRNA sequence of rabbit T1R3 is
485 MK182098.
486 Immunoﬂuorescence detection for the sweet receptor
487 subunits, T1R2 and T1R3, and the classical marker for
488 enteroendocrine cells, chromogranin A, was performed on
489 frozen tissue sections of rabbit duodenum and jejunum. As
f8 490 shown in Figure 8, T1R2 and T1R3 were co-expressed in the
491 same cell (Figure 8A). Furthermore, both T1R2 and T1R3
492 were co-expressed with chromogranin A, conﬁrming receptor
493 subunits expression in the enteroendocrine cell (Figure 8B).
494 ■ DISCUSSION
495 Feeding of low-level antibiotics has been a routine procedure
496 for controlling enteric pathogens, preventing disease and
497improving health and growth, in particular in post-weaning
498animals.24 However, increasing antibiotic resistance and rising
499consumer concern over prophylactic antibiotic use in animal
500production has led to a concerted search for eﬀective
501alternatives. In humans, oral rehydration therapy, which relies
502on absorption of glucose via SGLT1, activating electrolyte and
503water absorption, is a safe and eﬀective method for the
504treatment of E. coli- and Vibrio cholerae-induced diarrhea.1 The
505discovery that sensing of sugars and sweeteners by the gut-
506expressed sweet receptor T1R2-T1R3 enhances the expression
507and activity of SGLT14 has allowed the design of novel
508strategies for animal nutrition that use artiﬁcial sweeteners to
509combat diarrheal and enteric diseases.25
510E. coli-induced diarrhea is endemic in rabbits and results in
511high rates of morbidity and mortality. In the EU, artiﬁcial
512sweeteners are not permitted to be used in rabbit feed.
513We hypothesized that the rabbit intestine expresses the
514intestinal sweet receptor T1R2-T1R3 and that a natural high
515intensity sweetener (stevia) activates the receptor leading to
516SGLT1 upregulation, improving E. coli-induced enteric
517disorders. The supplement used in this study contained a
518small amount (2%) of capsicum oleoresin (4.9 μM capsaicin)
519shown to inﬂuence immunity. However, using heterologous
520expression of rabbit T1R2-T1R3, we have determined that
521capsaicin does not activate rabbit T1R2-T1R3. In contrast,
522stevia leaf extract (SL) activates the receptor in a dose-
523dependent manner (unpublished data).
Figure 6. Alignment of rabbit T1R2 mRNA sequence with the
corresponding region of cow, pig, human, mouse, and rat T1R2
(numbers in parentheses relate to initiating nucleotide).
Figure 7. Radial phylogram, derived from amino acid sequences,
depicting the phylogenetic relationship of rabbit T1R3 to various
mammalian homologs. The scale bar represents the number of
substitutions per amino acid position.
Figure 8. Co-expression of T1R2 and T1R3 in rabbit small intestine.
(A) Representative image showing expression of T1R2 (green), T1R3
(red), and merged image (yellow) in serial sections of rabbit small
intestine as determined by double immunohistochemistry. (B)
Typical image showing expression of T1R2 or T1R3 (green), the
enteroendocrine marker, chromogranin A (ChA, red), and merged
image (yellow). Speciﬁcity of primary antibodies for T1R2 and T1R3
has been validated in mice.6 Omission of primary antibodies for T1R2
or T1R3 showed no nonspeciﬁc immunoreactivity with secondary
antibodies (-T1R2 control and -T1R3 control). All images were taken
under 400× magniﬁcation; scale bars represent 20 μm.
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524 Works in the laboratory of Tavakkolizadeh and col-
525 leagues26,27 have questioned the role of vagal aﬀerent ﬁbers
526 in SGLT1 regulation by vagotomy and deaﬀerentation with 1
527 mg of capsaicin applied per animal. They have concluded that
528 vagal deaﬀerentation abolishes SGLT1 upregulation in
529 response to increased luminal glucose. They have further
530 proposed that the speciﬁc involvement of vagal aﬀerent ﬁbers
531 and the enteric nervous system in glucose-sensing initiated
532 regulatory pathway controlling SGLT1 expression remains
533 unclear.27
534 Bates et al.28 have shown that guinea pigs treated with
535 vehicle and thus having intact vagal aﬀerent ﬁbers were able to
536 increase the ability to enhance intestinal glucose transport
537 when switched from a low- to a high-carbohydrate containing
538 diet. In contrast, animals that orally received a 32.8 mM
539 solution of capsaicin demonstrated no adaptation to alterations
540 in dietary composition.28 Interestingly, Nassar et al.29 have
541 shown that capsaicin (160 and 800 μM) reduces intestinal
542 alanine absorption when perfused either intraluminally or
543 applied topically to the vagus nerve, concluding the
544 involvement of vagal capsaicin sensitive primary aﬀerent ﬁbers
545 in this inhibitory mechanism.29 Thus, it appears that capsaicin
546 may have a generalized eﬀect on inhibiting a range of intestinal
547 nutrient absorptive processes.
548 The results of studies carried out by Stearns et al.26,27 and
549 Bates et al.28 are in contrast to this study. In our study, rabbits
550 fed diets that included stevia and capsaicin (maximum
551 capsaicin concentration, 4.9 μM) were able to upregulate
552 glucose transporter expression/activity compared to those fed
553 the same diet without stevia and capsaicin.
554 We have shown recently that electric ﬁeld stimulation of an
555 isolated segment of the intestine results in a 2- to 3-fold
556 increase in SGLT1 upregulation.6 This increase is abolished in
557 the presence of the nerve blocking agent tetrodotoxin,
558 indicating the involvement of the enteric nervous system in
559 the regulatory pathway. We used this strategy because sensing
560 of glucose or artiﬁcial sweeteners via T1R2-T1R3, expressed in
561 enteroendocrine cells, stimulates GLP-2 release, and GLP-2 via
562 binding to its receptor (GLP-2R) present in enteric neurons
563 induces an action potential.30 We showed that electric ﬁeld
564 stimulation of enteric neurons induces a neural response
565 leading to secretion of speciﬁc neuropeptides that upregulate
566 SGLT1 expression in the neighboring absorptive enterocyte by
567 enhancing the half-life of SGLT1 mRNA and thus increased
568 SGLT1 protein abundance.6 Our studies strongly support the
569 involvement of enteric neurons in a glucose-sensing initiated
570 pathway regulating SGLT1 expression.6 Additional studies are
571 required to address if there is a speciﬁc involvement of the
572 vagus nerve in the SGLT1 regulatory pathway.
573 In this study, we determined the eﬀect of supplementation of
574 feed with an additive containing SL on rabbit intestinal SGLT1
575 expression as sweeteners are known to enhance Na+-dependent
576 glucose absorption in other mammalian species.4,12,13 Since the
577 regulatory pathway controlling SGLT1 expression/function is
578 initiated by activation of the gut-expressed sweet receptor
579 T1R2-T1R3, we aimed to identify if these receptor subunits
580 were expressed in the rabbit intestine. The gene for rabbit
581 T1R2 has previously been identiﬁed from the rabbit genome
582 sequence located on chromosome 13 (NCBI OryCun2.0
583 Annotation Release 102); however, no information was
584 available for rabbit T1R3. To determine the expression of
585 T1R2 and T1R3 in the rabbit intestine, a PCR-based strategy
586 was used to demonstrate that the rabbit intestine does indeed
587express both receptor subunits T1R2 and T1R3 at the mRNA
588level. Moreover, by immunohistochemistry, we showed that
589T1R2 and T1R3 proteins are co-expressed in the same
590intestinal enteroendocrine cell. Furthermore, SGLT1 mRNA,
591protein abundance, and glucose transport function were
592increased ∼2-fold by dietary inclusion of SL, providing a
593higher capacity for the rabbit intestine to absorb glucose,
594electrolyte, and water. There was also a 1.4-fold increase in
595villus height in rabbits consuming SL likely due to GLP-2
596action.13 In these dietary studies, we maintained rabbits on diet
597with and without SL for 9 days. We have shown SGLT1
598upregulation, with a similar increase in magnitude after 1 or 5
599days in response to increased dietary carbohydrates or
600sweeteners,4,6 indicating that an increase in SGLT1 expression
601occurs in existing absorptive enterocytes.6,7 However, since this
602was the ﬁrst time that we were assessing potential SGLT1
603upregulation in response to inclusion of a natural sweetener in
604the feed of rabbits, we selected a 5 day dietary trial in order to
605cover intestinal epithelial cell turnover that takes 4−5 days in
606the majority of species. This period was extended to 9 days
607because of the researcher travel delays from the UK to France
608for harvesting rabbit intestinal tissues.
609We also assessed the eﬀect of supplementation of rabbit feed
610with SL on relieving E. coli-induced enteric disorders and
611observed that inclusion of SL in the feed decreases morbidity
612associated with disease. Although we did not observe a linear
613dose response, there was a clear trend for improved
614morbidities at the two lower doses. Such hormetic responses
615to plant-based supplements are common; very low doses are
616beneﬁcial, whereas higher doses are nonspeciﬁc and
617detrimental.31 To our knowledge, this is the ﬁrst report
618evaluating the eﬀect of a natural sweetener on rabbit health and
619performance and the associated molecular mechanisms.
620The E. coli challenge elicited a marked impact on
621performance characterized by blunted feed intake, decreased
622daily gain, and eﬃciency of growth. These are classical signs of
623infection that not only lead to stressed animals but also have a
624devastating economic impact in rabbit production. The use of
625artiﬁcial sweeteners to prevent decreased performance during
626stress has been explored previously. For example, Sterk et al.32
627reported that supplementation of weanling piglets with
628artiﬁcial sweeteners prevented the decrease in feed intake
629around weaning. Similar observations have been made for
630receiving feedlot cattle with respect to both feed intake33 and
631daily weight gain.34 Whilst, in this study, the inclusion of SL in
632the feed had some impact on feed intake, the major eﬀect was
633at the gut level where activation of gut-expressed T1R2-T1R3
634by sweeteners results in the secretion of GLP-2, a gut hormone
635that can alter appetite,35 and also an increase the intestinal
636uptake of glucose leading to improved eﬃciency of growth.6 It
637has indeed been shown that artiﬁcial sweeteners directly
638introduced into the lumen of the intestine, bypassing the oral
639cavity, lead to an increase in expression of SGLT1 and higher
640rates of intestinal glucose absorption.27
641It was noteworthy that the E. coli challenge in this study was
642quite severe, with the mortality rate peaking at nearly 60%
643during the clinical trials in some groups. Despite the severity of
644the disease challenge, the supplement, at lower doses, showed a
645trend for a positive eﬀect on cumulative morbidities. This
646observation was consistent with those we made during our
647preliminary experiments to establish the optimal timing and
648dose of inoculation (data not shown). A previous work using
649an artiﬁcial high-intensity sweetener has revealed similar eﬀects
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650 during enteric disease challenge,36 but this is the ﬁrst report on
651 the impact of a natural high-intensity sweetener for prevention
652 of clinical signs of enteritis in rabbits. The positive impact of
653 the supplement on morbidities, combined with the molecular
654 responses we observed, are consistent with an increase in GLP-
655 2 secretion, which is known to be essential for gut repair after
656 injury,25 and also an enhancement in nutrient absorption.6 In
657 this scenario, the increased glucose, electrolyte, and water
658 absorption at the intestinal level likely decreased the clinical
659 signs of disease associated with diarrhea, and the enteric
660 lesions caused by the pathogen were likely reduced or repaired
661 in supplemented animals due to the GLP-2 eﬀect.
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